Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Rapid evolution may have helped bats avoid cancer, study finds
The researchers sequenced the genomes of the Jamaican fruit bat (pictured) and the Mesoamerican mustached bat.

It may also help them tolerate viruses.
 

A study has suggested that rapid evolution may be the reason why bats are able to avoid cancer, and also tolerate viral infections like SARS-CoV-2.

The researchers aimed to investigate bats’ low cancer rates and robust immune system, with the theory that it may have implications for human health. For example, performing comparative genomic analysis of bats against mammals that are susceptible to cancer may lead to new discoveries on the causes of cancer, and its links with immunity.

It could also further our understanding of why bats are tolerant to zoonotic viruses, such as SARS-CoV-2, before they get passed onto humans. This could lead to work that may better prevent disease outbreaks from animals to people.

The investigation involved the researchers using the Oxford Nanopores Technologies long-read platform to sequence the genomes of two bat species, the Jamaican fruit bat and the Mesoamerican mustached bat, which have key evolutionary positions.

They then conducted a comparative genomic analysis with a diverse collection of bats and other mammals.

This found genetic adaptations in six DNA repair-related proteins and 46 proteins in bats that were cancer-related. It revealed that these altered cancer-related genes were twice as enriched in the bats compared to other mammals.

The analysis identified antiviral genes that showed evidence of rapid evolution. There were also positive selection signs in 33 tumour suppressors and 6 DNA-repair genes which may contribute to bats’ increased longevity and reduced cancer rates.

This shows that the immune systems of bats rely on bat-wide and lineage-specific evolution among their genes, which suggests diverse immune strategies.

Armin Scheben, the lead author, said: “By generating these new bat genomes and comparing them to other mammals we continue to find extraordinary new adaptations in antiviral and anticancer genes,

“These investigations are the first step towards translating research on the unique biology of bats into insights relevant to understanding and treating aging and diseases, such as cancer, in humans.”

The full study can be found in the Genome Biology and Evolution journal.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

VMD responds to Solensia injection concerns

News Story 1
 The VMD has added anaphylaxis to the SPC of Solensia 7 mg/ml Solution for Injection for Cats.

It says that this is a rare side effect, with such adverse events affecting fewer than three animals for every 1000 doses of Solensia sold.

Solensia is used to alleviate osteoarthritis pain in cats. It contains the active ingredient frunevetmab.

Anaphylaxis joins effects such as alopecia, dermatitis, pruritus on the list of adverse effects.

The VMD says that is constantly reviewing adverse event data for all medicines. 

Click here for more...
News Shorts
Applications open for RCVS Fellowship

The Royal College of Veterinary Surgeons (RCVS) has opened applications for veterinary surgeons to join the RCVS Fellowship.

The RCVS Fellowship is a learned society which works to advance veterinary standards and promote scientific excellence.

Veterinary surgeons can enter the RCVS Fellowship through three routes, each with different criteria. This enables people with a range of expertise and experience to join the society.

The routes are: Meritorious Contributions to Clinical Practice, Meritorious Contributions to Knowledge and Meritorious Contributions to the Profession.

Applicants must share a summary of their contributions to the profession, including examples of significant works produced throughout their career. The application will then be assessed by a panel of judges against a set of criteria.

Veterinary surgeons have until 4pm on Friday, 14 March to submit applications. More information, including requirements and guidance can be found here.